Evidence map›Paper›PMID 38498918›Full record

ArticleOrganic letters2024

Selective Late-Stage Functionalization of Tryptophan-Containing Peptides To Facilitate Bioorthogonal Tetrazine Ligation.

Nagaraju Mupparapu, Basir Syed, Diem N Nguyen, Thao H Vo, Angelica Trujillo, Sherif I Elshahawi

Open access · greenAbstract read
In one paragraph

Article in Organic letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nagaraju MupparapuDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy (CUSP), Rinker Health Science Campus, Chapman University, Irvine, California 92618, United States.
Basir SyedDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy (CUSP), Rinker Health Science Campus, Chapman University, Irvine, California 92618, United States.
Diem N NguyenDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy (CUSP), Rinker Health Science Campus, Chapman University, Irvine, California 92618, United States.
Thao H VoDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy (CUSP), Rinker Health Science Campus, Chapman University, Irvine, California 92618, United States.
Angelica TrujilloDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy (CUSP), Rinker Health Science Campus, Chapman University, Irvine, California 92618, United States.
Sherif I ElshahawiDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy (CUSP), Rinker Health Science Campus, Chapman University, Irvine, California 92618, United States.ORCID 0000-0003-1879-1552
Chapman University · US

Funding

Mechanisms and In Vivo Activity of a Next Generation Daptomycin AntibioticR03AI168826 · NIAID · CHAPMAN UNIVERSITY · PI ELSHAHAWI, SHERIF I · 2023 to 2024
$138k
NIAID NIH HHS R03 AI168826
6 · The paper itself

Abstract

Site-selective modification of complex peptides and the functionalization of their C-H bonds hold great promise for expanding their use in therapeutics and biomedical research. Herein, we leverage the power of late-stage chemoenzymatic catalysis using an indole prenyltransferase (IPT) enzyme and alkyl diphosphates to specifically modify the indole ring of tryptophan in clinically relevant peptides. Furthermore, the installed handle enables bioorthogonal click chemistry through an inverse electron-demand Diels-Alder (IEDDA) reaction with a biotin-conjugated tetrazine probe.

Indexed as

Heterocyclic CompoundsTryptophanCycloaddition ReactionIndolesPeptidesHeterocyclic CompoundsIndolesPeptidesTryptophan

Identifiers

PMID38498918
PMCPMC10987333
OpenAlexW4392900821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.